Invention Grant
- Patent Title: Inhibitors of histone deacetylase
-
Application No.: US15786134Application Date: 2017-10-17
-
Publication No.: US10662199B2Publication Date: 2020-05-26
- Inventor: Edward Holson , Florence Fevrier Wagner , Michel Weiwer , Li-Huei Tsai , Stephen J. Haggarty , Yan-Ling Zhang
- Applicant: The Broad Institute, Inc. , The General Hospital Corporation , Massachusetts Institute of Technology
- Applicant Address: US MA Cambridge US MA Boston US MA Cambridge
- Assignee: The Broad Institute, Inc.,The General Hospital Corporation,Massachusetts Institute of Technology
- Current Assignee: The Broad Institute, Inc.,The General Hospital Corporation,Massachusetts Institute of Technology
- Current Assignee Address: US MA Cambridge US MA Boston US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07D491/107
- IPC: C07D491/107 ; C07D401/12 ; C07D403/12 ; C07D309/08 ; C07D311/82 ; C07D333/20 ; C07D405/12 ; C07D493/08 ; C07D211/22 ; C07D213/40 ; C07C271/28 ; C07C275/30 ; C07C275/40 ; C07C281/06 ; C07C211/52 ; C07C233/43 ; C07C233/56 ; C07C233/62 ; C07C235/82 ; C07D409/12 ; C07C237/20 ; C07D205/06 ; C07D213/56 ; C07D241/12 ; C07D333/24 ; C07C237/24 ; C07D205/04 ; C07D209/44 ; C07D209/52 ; C07D211/34 ; C07D211/62 ; C07D295/195 ; C07D471/04 ; A61K31/167 ; A61K31/402 ; A61K31/403 ; A61K31/4035 ; A61K31/437 ; A61K31/445 ; A61K31/351 ; A61K31/352 ; A61K31/381 ; A61K31/397 ; A61K31/415 ; A61K31/4178 ; A61K31/439 ; A61K31/4418 ; A61K31/4433 ; A61K31/4439 ; A61K31/4535 ; A61K31/4545 ; A61K31/496 ; A61K31/4965 ; A61K31/50 ; A61K31/501 ; A61K31/519 ; A61K31/5377 ; C07C233/42 ; C07D231/04 ; C07D237/04 ; C07D295/185 ; C07D311/04 ; C07D407/12 ; C07D487/04 ; C07D487/10 ; C07D491/08

Abstract:
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, wherein U, J, V, X, R2a, R2b, R2c, R5 and t are as described herein. The present invention relates generally to inhibitors of histone deacetylase and to methods of making and using them. These compounds are useful for promoting cognitive function and enhancing learning and memory formation. In addition, these compounds are useful for treating, alleviating, and/or preventing various conditions, including for example, neurological disorders, memory and cognitive function disorders/impairments, extinction learning disorders, fungal diseases and infections, inflammatory diseases, hematological diseases, and neoplastic diseases in humans and animals.
Public/Granted literature
- US20180099977A1 INHIBITORS OF HISTONE DEACETYLASE Public/Granted day:2018-04-12
Information query